These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 17931661)

  • 1. Detection of HDM2 and VEGF co-expression in cancer cell lines: novel effect of HDM2 antisense treatment on VEGF expression.
    Narasimhan M; Rose R; Karthikeyan M; Rathinavelu A
    Life Sci; 2007 Oct; 81(17-18):1362-72. PubMed ID: 17931661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of HDM2 as a regulator of VEGF expression in cancer cells.
    Narasimhan M; Rose R; Ramakrishnan R; Zell JA; Rathinavelu A
    Life Sci; 2008 Jun; 82(25-26):1231-41. PubMed ID: 18504050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1alpha and Hdm2.
    LaRusch GA; Jackson MW; Dunbar JD; Warren RS; Donner DB; Mayo LD
    Cancer Res; 2007 Jan; 67(2):450-4. PubMed ID: 17234751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
    Riedel F; Götte K; Li M; Hörmann K; Grandis JR
    Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of the inhibition of Hdm2 expression in human osteosarcoma cells using antisense oligonucleotides.
    Geiger T; Hüsken D; Weiler J; Natt F; Woods-Cook KA; Hall J; Fabbro D
    Anticancer Drug Des; 2000 Dec; 15(6):423-30. PubMed ID: 11716435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of spliced variants of the proto-oncogene HDM2 in colorectal cancer.
    Yu Z; Zhang B; Cui B; Wang Y; Han P; Wang X
    Cancer; 2012 Feb; 118(4):1110-8. PubMed ID: 21761395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting chemotherapy-induced VEGF up-regulation by VEGF antisense oligonucleotides in HNSCC cell lines.
    Riedel F; Götte K; Goessler U; Sadick H; Hörmann K
    Anticancer Res; 2004; 24(4):2179-83. PubMed ID: 15330158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways.
    Fang J; Xia C; Cao Z; Zheng JZ; Reed E; Jiang BH
    FASEB J; 2005 Mar; 19(3):342-53. PubMed ID: 15746177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of antisense oligodeoxynucleotide on expression of vascular endothelia growth factor by human hepatocarcinoma cells.
    Qiu MB; Zhang JX; Liu LM; Gong BD; Wu BL; Zhu SS; Wen Y
    Hepatobiliary Pancreat Dis Int; 2004 Nov; 3(4):552-7. PubMed ID: 15567744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of VEGF-A/VEGF-C antisense oligodeoxynucleotide on angiogenesis, lymphangiogenesis, and tumor growth of breast cancer].
    Chen JS; Zhang YJ; Hu SE; Zhang HQ
    Ai Zheng; 2007 Sep; 26(9):972-6. PubMed ID: 17927855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 in colorectal adenocarcinoma is associated with p53 accumulation and hdm2 overexpression.
    Cressey R; Pimpa S; Tontrong W; Watananupong O; Leartprasertsuke N
    Cancer Lett; 2006 Feb; 233(2):232-9. PubMed ID: 15921850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's lymphoma cells express alternatively spliced forms of HDM2 with multiple effects on cell cycle control.
    Sánchez-Aguilera A; García JF; Sánchez-Beato M; Piris MA
    Oncogene; 2006 Apr; 25(18):2565-74. PubMed ID: 16331255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
    Phillips A; Blaydes JP
    Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of p53 function in synovial sarcoma cells by inhibition of p53-HDM2 interaction.
    D'Arcy P; Ryan BA; Brodin B
    Cancer Lett; 2009 Mar; 275(2):285-92. PubMed ID: 19081178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of hdm2 by stress-induced hdm2alt1 in tumor and nontumorigenic cell lines correlating with p53 stability.
    Dias CS; Liu Y; Yau A; Westrick L; Evans SC
    Cancer Res; 2006 Oct; 66(19):9467-73. PubMed ID: 17018602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental therapy of human prostate cancer by inhibiting MDM2 expression with novel mixed-backbone antisense oligonucleotides: in vitro and in vivo activities and mechanisms.
    Wang H; Yu D; Agrawal S; Zhang R
    Prostate; 2003 Feb; 54(3):194-205. PubMed ID: 12518324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GC-selective DNA-binding antibiotic, mithramycin A, reveals multiple points of control in the regulation of Hdm2 protein synthesis.
    Phillips A; Darley M; Blaydes JP
    Oncogene; 2006 Jul; 25(30):4183-93. PubMed ID: 16501602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [VEGF antisense oligonucleotide inhibits the expression of vascular endothelial growth factor in human leukemic cell lines].
    Zhang L; Tu ZG; Feng WL; Huang ZG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):22-5. PubMed ID: 14990072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.